NCT01304316View on ClinicalTrials.gov

Dose-Escalation Safety and Pharmacokinetic Study of K305

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Anesthesia
Interventions
DRUG

Tetracaine HCl 3% and Oxymetazoline HCl 0.05%

Tetracaine HCl 3% and Oxymetazoline HCl 0.05%

Trial Locations (1)

19104

University of Pennsylvania, School of Dental Medicine, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Ground Zero Pharmaceuticals

INDUSTRY

collaborator

Rho, Inc.

INDUSTRY

lead

St. Renatus, LLC

INDUSTRY

NCT01304316 - Dose-Escalation Safety and Pharmacokinetic Study of K305 | Biotech Hunter | Biotech Hunter